Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH Logo National Institutes of Health

Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name NCATS Issued NOFO Number Activity Code Posting Date Expiration Date Opportunity Type
Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed) ✔ RFA-TR-23-018 UT1 11/21/2023 02/23/2026 NA
Notice of Termination of PAR-21-340 "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trial Not Allowed)” ✔ NOT-TR-24-001 11/08/2023 Notice of Change to Funding Opportunity
Notice of Special Interest (NOSI): Collaborative and Innovative Research to Advance Regulatory Science: Partnership of FDA Centers of Excellence in Regulatory Science and Innovation (CERSI) and NIH Clinical and Translational Science Award (CTSA) Programs ✔ NOT-TR-24-006 UG3/UH3 11/02/2023 10/17/2024 Notice of Special Interest
Notice of Information: Technical Assistance Webinar for PAR-22-167: “Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)” ✔ NOT-TR-24-003 11/02/2023 Notice of Information
Notice of Change to Update Part 2, Section III, PAR-22-167, Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) ✔ NOT-TR-24-004 11/02/2023 Notice of Change to Funding Opportunity
Notice of Participation of the Food and Drug Administration in PAR-22-167, Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) ✔ NOT-TR-24-005 11/02/2023 Notice of Information
Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentor... ✘ NOT-OD-24-001 Admin Supp 10/26/2023 02/16/2024 Notice of Special Interest
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional): Notice of Technical Webinar ✔ NOT-TR-24-002 11/07/2023 Notice of Information
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional) ✔ PAR-24-054 RC2 11/07/2023 09/14/2026 NA
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed) ✘ PAR-24-046 R21 10/20/2023 11/19/2024 NA
Showing Row 51 to 60 of 377

Last updated on April 19, 2024